drugset / Trial / NCT00004479

Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope

NCT00004479 ↗

RandomizedDouble-blindTreatment

Summary

OBJECTIVES: Determine the efficacy of midodrine, a selective alpha 1 adrenergic agonist, in preventing neurally mediated syncope.

Timeline

Start
1999-03
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Midodrine Small molecule — —

Indications

No indication recorded.